Synergistic inhibition of respiration in brain mitochondria by nitric oxide and dihydroxyphenylacetic acid (DOPAC): Implications for Parkinson's disease

Neurochemistry International

Volumn 47, Issue 3, 2005, Pages 173-182

  Nunes, Carla ^a   Almeida, Leonor ^a   Laranjinha, João ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

DOPAC; Mitochondrial dysfunction; Nitric oxide; Nitroxyl anion; Parkinson's disease

Indexed keywords

CYTOCHROME C OXIDASE; DIHYDROXYPHENYLACETIC ACID; FERROCYANIDE; METMYOGLOBIN; NITRIC OXIDE; OXYGEN;

ANIMAL TISSUE; ARTICLE; BRAIN MITOCHONDRION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME ACTIVITY; MALE; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXYGEN CONSUMPTION; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; RESPIRATION DEPRESSION;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; BRAIN; CELL RESPIRATION; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ELECTRON TRANSPORT; ELECTRON TRANSPORT COMPLEX IV; FEEDBACK, BIOCHEMICAL; FERROCYANIDES; MALE; METMYOGLOBIN; MITOCHONDRIA; NITRIC OXIDE; OXIDATION-REDUCTION; OXYGEN; OXYGEN CONSUMPTION; PARKINSON DISEASE; RATS; RATS, WISTAR; SUBCELLULAR FRACTIONS;

EID: 20544459248     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2005.03.005     Document Type: Article

References (68)

1. W. Ambroziak, and R. Pietruszko Human aldehyde dehydrogenase. Activity with aldehyde metabolites of monoamines, diamines, and polyamines J. Biol. Chem. 266 1991 13011 13018
2. F. Antunes, D. Han, D. Rettori, and E. Cadenas Mitochondrial damage by nitric oxide is potentiated by dopamine in PC12 cells Biochim. Biophys. Acta 1556 2002 233 238
3. F. Antunes, C. Nunes, J. Laranjinha, and E. Cadenas Redox interactions of nitric oxide with dopamine and its metabolites Toxicology 208 2005 207 212
4. M.F. Beal, B.T. Hyman, and W. Koroshetz Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative disease? TINS 16 1993 125 131
5. D. Ben-Shachar, R. Zuk, and Y. Glinka Dopamine neurotoxicity: inhibition of mitochondrial respiration J. Neurochem. 64 1995 718 723
6. G. Benzi, and A. Moretti Age-and peroxidative stress-related modifications of the cerebral enzymatic activities linked to mitochondria and the glutathione system Free Radic. Biol. Med. 19 1995 77 101
7. S.B. Berman, and T.G. Hastings Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease J. Neurochem. 73 1999 1127 1137
8. H. Bernheimer, W. Birkmayer, O. Hornykiewicz, K. Jellinger, and F. Seitelberger Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations J. Neurol. Sci. 20 1973 415 455
9. J.P. Bolaños, A. Almeida, V. Stewart, S. Peuchen, J.M. Land, J.B. Clark, and S.J.R. Heales Nitric oxide-mediated mitochondrial damage in the brain: mechanisms and implications for neurodegenerative diseases J. Neurochem. 68 1997 2227 2240
10. A. Boveris, L.E. Costa, J.J. Poderoso, M.C. Carreras, and E. Cadenas Regulation of mitochondrial respiration by oxygen and nitric oxide Ann. N. Y. Acad. Sci. 899 2000 121 135
11. A. Boveris, S.L. Arnaiz, S. Alvarez, L.E. Costa, and L. Valdez The mitochondrial production of free radicals T. Yoshikawa S. Toyokuni Y. Yamamoto Y. Naito Free radicals in Chemistry Biology and Medicine 2000 OICA International 256 261
12. D.S. Bredt, and S.H. Snyder Nitric oxide: a physiological messenger molecule Annu. Rev. Biochem. 63 1994 175 195
13. G.C. Brown Nitric oxide and mitochondrial respiration Biochim. Biophys. Acta 1411 1999 351 369
14. G.C. Brown NO regulates mitochondrial respiration and cell functions by inhibiting cytochrome oxidase FEBS Lett. 369 1995 136 139
15. G.C. Brown, and C.E. Cooper Nanomolar concentrations of nitric oxide reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome oxidase FEBS Lett. 356 1994 295 298
16. G.C. Brown Regulation of mitochondrial respiration by nitric oxide inhibition of cytochrome c oxidase Biochim. Biophys. Acta 1504 2001 46 57
17. G.C. Brown, and V. Borutaite Inhibition of mitochondrial respiratory complex I by nitric oxide, peroxynitrite and S-nitrosothiols Biochim. Biophys. Acta 1658 2004 44 49
18. E. Cadenas, J.J. Poderoso, F. Antunes, and A. Boveris Analysis of the pathways of nitric oxide utilization in mitochondria Free Radic. Res. 33 2000 747 756
19. A. Cassina, and R. Radi Different inhibitory actions of NO and peroxynitrite on mitochondrial electron transport Arch. Biochem. Biophys. 328 1996 309 316
20. B. Chance, and G.R. Williams The respiratory chain and oxidative phosphorylation Adv. Enzymol. 17 1956 65 134
21. M.W. Cleeter, J.M. Cooper, V.M. Darley-Usmar, S. Moncada, and A.H. Schapira Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases FEBS Lett. 345 1994 50 54
22. J.A. Cook, D.A. Wink, V. Blount, M.C. Krishna, and I. Hanbauer Role of antioxidants in the nitric oxide-elicited inhibition of dopamine uptake in cultured mesencephalic neurons. Insights into potential of nitric oxide-mediated neurotoxicity Neurochem. Int. 28 1996 609 617
23. J.F. Cubells, S. Rayport, G. Rajendran, and D. Sulzer Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress J. Neurosci. 14 1994 2260 2271
24. V.L. Dawson, and T.M. Dawson Nitric oxide in neurodegeneration Prog. Brain Res. 118 1998 215 229
25. T. Dehmer, J. Lindenau, S. Haid, J. Dichgans, and J.B. Schulz Deficiency of inducible nitric oxide synthase protects against MPTP toxicity in vivo J. Neurochem. 74 2000 2213 2216
26. P.L. Feldman, O.W. Griffith, and D.J. Stuehr The surprising life of nitric oxide Chem. Eng. News 71 1993 26 38
27. J. Garthwaite, and C.L. Boulton Nitric oxide signaling in the central nervous system Annu. Rev. Physiol. 57 1995 683 706
28. P. Ghafourifar, and C. Richter Nitric oxide synthase activity in mitochondria FEBS Lett. 418 1997 291 296
29. M. Gerlach, D. Blum-Degen, J. Lan, and P. Riederer Nitric oxide in the pathogenesis of Parkinson's disease Adv. Neurol. 80 1999 239 245
30. C. Giulivi, J.J. Poderoso, and A. Boveris Production of nitric oxide by mitochondria J. Biol. Chem. 273 1998 11038 11043
31. P. Hantraye, E. Brouillet, R. Ferrante, S. Palfi, R. Dolan, R.T. Matthews, and M.F. Beal Inhibition of neuronal nitric oxide synthase prevents MPTP-induced Parkinsonism in baboons Nat. Med. 2 1996 1017 1021
32. T.G. Hastings, and M.J. Zigmond Loss of dopaminergic neurons in Parkinsonism: possible role of reactive dopamine metabolites J. Neural Transm. Suppl. 49 1997 103 110
33. Y. Itzhak, and S.F. Ali The neuronal nitric oxide synthase inhibitor, 7-nitroindazole, protects against methamphetamine-induced neurotoxicity in vivo J. Neurochem. 67 1996 1770 1773
34. W.M. Keung, and B.L. Vallee Daidzin and its antidipsotropic analogs inhibit serotonin and dopamine metabolism in isolated mitochondria Proc. Natl. Acad. Sci. U.S.A. 95 1998 2198 2203
35. R. Kissner, T. Nauser, P. Bugnon, P.G. Lye, and W.H. Koppenol Formation and properties of peroxynitrite as studied by laser flash photolysis, high-pressure stopped-flow techique, and pulse radiolysis Chem. Res. Toxicol. 10 1997 1285 1292
36. P. Klivenyi, O.A. Andreassen, R.J. Ferrante, E. Lancelot, D. Reif, and M.F. Beal Inhibition of neuronal nitric oxide synthase protects against MPTP toxicity Neuroreport 11 2000 1265 1268
37. I.J. Kopin Catecholamine metabolism: basic aspects and clinical significance Pharmacol. Rev. 37 1985 333 364
38. J. Laranjinha, and E. Cadenas Oxidation of DOPAC by nitric oxide. Effect of superoxide dismutase J. Neurochem. 81 2002 892 900
39. M.J. LaVoie, and T.G. Hastings Peroxynitrite-and nitrite-induced oxidation of dopamine: implications for nitric oxide in dopaminergic cell loss J. Neurochem. 73 1999 2546 2554
40. C.P. Lee, L. Sottocasa, and L. Ernster Use of artificial acceptors for abbreviated phosphorylating electron trasnport: flavin-cytochrome c Methods Enzymol. 10 1967 33 37
41. G.T. Liberatore, V. Jackson-Lewis, S. Vukosavic, A.S. Mandir, M. Vila, W.G. McAuliffe, V.L. Dawson, T.M. Dawson, and S. Przedborski Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease Nat. Med. 5 1999 1403 1409
42. C.J. Lowenstein, and S.H. Snyder Nitric oxide, a novel biological messenger Cell 70 1992 705 707
43. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurements with the Folin phenol reagent J. Biol. Chem. 193 1951 265 275
44. E. Mignot, D. Laude, and J.L. Elghozi Kinetics of drug-induced changes in dopamine and serotonin metabolite concentrations in the CSF of the rat J. Neurochem. 42 1984 819 825
45. J.A. Molina, F.J. Jiménez-Jiménez, M. Ortí-Pareja, and J.A. Navarro The role of nitric oxide in neurodegeneration. Potential for pharmacological intervention Drugs Aging 12 1998 251 259
46. S. Moncada, R.M. Palmer, and E.A. Higgs Nitric oxide: physiology, pathophysiology, and pharmacology Pharmacol. Rev. 43 1991 109 142
47. H. Nohl, K. Staniek, B. Sobhian, S. Bahrami, H. Redl, and A.V. Kozlov Mitochondria recycle nitrite back to the bioregulator nitric monoxide Acta Biochim. Pol. 47 2000 913 921
48. J.J. Poderoso, M.C. Carreras, C. Lisdero, N. Riobó, F. Schopfer, and A. Boveris Nitric oxide inhibits electron transfer chain and increases superoxide radical production in rat heart mitochondria and submitochondrial particles Arch. Biochem. Biophys. 328 1996 85 92
49. S. Przedborski, V. Jackson-Lewis, R. Yokoyama, T. Shibata, V.L. Dawson, and T.M. Dawson Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity Proc. Natl. Acad. Sci. U.S.A. 93 1996 4565 4571
50. A.D. Rabinovic, D.A. Lewis, and T.G. Hastings Role of oxidative changes in the degeneration of dopamine terminals after injection of neurotoxic levels of dopamine Neuroscience 101 2000 67 76
51. C.A. Ragan, M.T. Wilson, V.M. Darley-Usmar, and P.N. Lowe Subfractionation of mitochondria and isolation of the proteins of oxidative phosphorylation V.M. Darley-Usmar D. Rickwood M.T. Wilson Mitochondria, a Practical Approach 1987 IRL Press London 79 112
52. P.R. Rich Quinone binding sites of membrane proteins as targets for inhibitors Pestic. Sci. 47 1996 287 296
53. N.A. Riobó, E. Clementi, M. Melani, A. Boveris, E. Cadenas, S. Moncada, and J.J. Poderoso Nitric oxide inhibits mitochondrial NADH:ubiquinone reductase activity through peroxynitrite formation Biochem. J. 359 2001 139 145
54. R.E. Rosenthal, F. Hamud, G. Fiskum, P.J. Varghese, and S. Sharpe Cerebral ischemia and reperfusion: prevention of brain mitochondrial injury by lidoflazine J. Cereb. Blood Flow Metab. 7 1987 752 758
55. R. Roskoski Jr., and L.M. Roskoski Activation of tyrosine hydroxylase in PC12 cells by the cyclic GMP and cyclic AMP second messenger systems J. Neurochem. 48 1987 236 242
56. J.B. Schulz, R.T. Matthews, T. Klockgether, J. Dichgans, and M.F. Beal The role of mitochondrial dysfunction and neuronal nitric oxide in animal models of neurodegenerative diseases Mol. Cell. Biochem. 174 1997 193 197
57. J.B. Schulz, R.T. Matthews, M.M.K. Muqit, S.E. Browne, and M.F. Beal Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice J. Neurochem. 64 1995 936 939
58. J. Segieth, L. Fowler, P. Whitton, and B. Pearce Nitric oxide-mediated regulation of dopamine release in the hippocampus in vivo Neuropharmacology 39 2000 571 577
59. S. Shiva, J.H. Crawford, A. Ramachandran, E.K. Ceaser, T. Hillson, P.S. Brookes, R.P. Patel, and V.M. Darley-Usmar Mechanisms of the interaction of nitroxyl with mitochondria Biochem. J. 379 2004 359 366
60. T.P. Singer Determination of the activity of succinate, NADH, choline and glycerophosphate dehydrogenases Methods Biochem. Anal. 22 1974 123 175
61. M. Steffen, T.M. Sarkela, A.A. Gybina, T.W. Steele, N.J. Trasseth, D. Kuehl, and C. Giulivi Metabolism of S-nitrosoglutathione in intact mitochondria Biochem. J. 356 2001 395 402
62. D. Sulzer, T.K. Chen, Y.Y. Lau, H. Kristensen, S. Rayport, and A. Ewing Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport J. Neurosci. 15 1995 4102 4108
63. A.W. Tank, H. Weiner, and J.A. Thurman Enzymology and subcellular localisation of aldehyde oxidation in rat liver. Oxidation of 3,4-dihydroxyphenylacetaldehyde derived from dopamine to 3,4- dihydroxyphenylacetic acid Biochem. Pharmacol. 30 1981 3265 3275
64. H.D. Tisdale Purification and properties of succinic-cytochrome c reductase (complex II-III) Methods Enzymol. 10 1967 213 215
65. D.C. Wallace, M.T. Lott, and M.D. Brown Mitochondrial defects in neurodegenerative diseases and aging M.F. Beal N. Howel I. Bodis-Wollner Mitochondria and Free Radicals in Neurodegenerative Diseases 1997 Wiley-Liss Inc. New York 277 289
66. G. Wegener, V. Volke, and R. Rosenberg Endogenous nitric oxide decreases hippocampal levels of serotonin and dopamine in vivo Br. J. Pharmacol. 130 2000 575 580
67. D.A. Wink, M. Feelisch, J. Fukuto, D. Chistodoulou, D. Jourd'heuil, M.B. Grisham, Y. Vodovotz, J.A. Cook, M. Krishna, W.G. DeGraff, S. Kim, J. Gamson, and J.B. Mitchell The cytotoxicity of nitroxyl: possible implications for the pathophysiological role of NO Arch. Biochem. Biophys. 351 1998 66 74
68. Z. Zhang, L. Huang, V.M. Shulmeister, Y. Chi, K.K. Kim, L.W. Hung, A.R. Crofts, E.A. Berry, and S.H. Kim Electron transfer by domain movement in cytochrome bc1 Nature 392 1998 677 684